IL17A and COVID-19: These observations suggest that elevated sCD14 may, at least in part, explain the increased frequency of IL-17-producing cells (74) and elevated plasma IL-17A levels in acute COVID-19 (41 ) and LC patients with ME/CFS (46, 75, 76).